Eradication treatment of Pseudomonas Aeruginosa in pediatric patients with Cystic Fibrosis.
A. Gulieva (Istanbul, Turkey), C. Yilmaz Yegit (Istanbul, Turkey), M. Yanaz (Istanbul, Turkey), M. Kalyoncu (Istanbul, Turkey), M. Selcuk (Istanbul, Turkey), G. Tastan (Istanbul, Turkey), B. Suzer (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)
Source: International Congress 2022 – Cystic fibrosis in children and adolescents
Session: Cystic fibrosis in children and adolescents
Session type: Thematic Poster
Number: 285
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gulieva (Istanbul, Turkey), C. Yilmaz Yegit (Istanbul, Turkey), M. Yanaz (Istanbul, Turkey), M. Kalyoncu (Istanbul, Turkey), M. Selcuk (Istanbul, Turkey), G. Tastan (Istanbul, Turkey), B. Suzer (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey). Eradication treatment of Pseudomonas Aeruginosa in pediatric patients with Cystic Fibrosis.. 285
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|